Treatment of Parkinson's disease: levodopa as the first choice Regina KatzenschlagerAndrew J. Lees Pages: ii19 - ii24
Recombinant adeno-associated viral vectors bring gene therapy for Parkinson's disease closer to reality Shin-ichi MuramatsuLijun WangKeiya Ozawa Pages: ii36 - ii40
Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists Tomoyoshi Kondo Pages: ii25 - ii29
Mitochondrial genotypes and cytochrome b variants associated with longevity or Parkinson's disease Masashi Tanaka Pages: ii11 - ii18
New drugs in the future treatment of Parkinson's disease Ruth DjaldettiEldad Melamed Pages: ii30 - ii35